Document is current
Any future updates will be listed below
-
Authors
Paoletti, M.
Monforte, M. https://orcid.org/0000-0002-4327-6969
Barzaghi, L.
Tasca, G.
Bergsland, N.
Faggioli, A.
Solazzo, F.
Manco, G.
Bortolani, S.
Torchia, E.
Ravera, B.
Deligianni, X.
Santini, F.
Ballante, E.
Figini, S.
Tartaglione, T.
Ricci, E.
Pichiecchio, A.
-
Funding
Funding for this research was provided by:
Ministero della Salute (RF-2016-02362914)
Università Cattolica del Sacro Cuore
- License Information
-
More Information
Article History
Received: 26 November 2024
Revised: 19 March 2025
Accepted: 20 March 2025
First Online: 2 April 2025
Declarations
:
: M. Monforte and E. Ricci provided central reading services for MRI scans generated in aTyr’s clinical trials of Resolaris (ATYR1940), pursuant to the terms of a Master Academic Services Agreement with the Catholic University of the Sacred Heart. A. Pichiecchio provided consultancy for Amicus Therapeutics, Sanofi and Genzyme. The other authors have no conflicts of interest to declare.
: This study was conducted in accordance with the amended Declaration of Helsinki and was approved by the Ethics Committee of Fondazione Policlinico Universitario A. Gemelli IRCCS (Prot. 7451/18 ID:1952). All subjects provided written informed consent for participation in this study.
